Health Economics›Breast cancer›Adjuvant chemotherapy, sequential regimens

Adjuvant chemotherapy, sequential regimens

Breast cancer · 26 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
iddEnPC Variant #01	—	R 54 021	14d	—	—	—	—	—
TX-CEX Variant #01	—	R 5 793	21d	—	—	—	—	1
iddEPC Variant #01	—	R 5 301	14d	—	—	—	—	1
FEC-D Variant #01	—	R 5 123	21d	—	29.0 mo	—	—	1
D-FEC Variant #01	—	R 5 123	21d	—	—	—	—	1
E-D Variant #01	—	R 4 935	28d	—	—	—	—	1
EC-D Variant #01	—	R 4 860	21d	—	—	—	—	1
D-EC Variant #01	—	R 4 558	21d	—	—	—	—	—
ddEC-T Variant #01	—	R 4 023	21d	—	—	—	—	1
ddFEC-ddD Variant #01	—	R 3 889	14d	—	—	—	—	—
AC-D Variant #01	—	R 3 477	21d	—	—	—	—	2
T-FEC Variant #01	—	R 3 449	21d	—	—	—	—	—
EP-ddCMF Variant #01	—	R 3 421	21d	—	—	—	—	—
ddEC-ddT Variant #01	—	R 3 315	14d	—	—	—	—	2
EC-T Variant #01	—	R 3 315	21d	—	—	—	—	2
FEC-P Variant #01	—	R 2 877	21d	—	—	—	—	—
ddE-iddCMF Variant #01	—	R 2 711	14d	—	—	—	—	—
EC-CMF Variant #01	—	R 2 602	28d	—	—	—	—	—
E-CMF Variant #01	—	R 2 439	21d	—	—	—	—	3
ddEC-ddCMF Variant #01	—	R 2 328	14d	—	75.9 mo	—	—	—
ddA-ddT-ddC Variant #01	—	R 1 931	14d	—	—	—	—	—
AC-T Variant #01	—	R 1 931	21d	—	—	—	—	2
FAC-T Variant #01	—	R 1 360	21d	—	—	—	—	—
ddAC-T Variant #01	—	R 1 272	14d	—	—	—	—	—
AC-CMF Variant #01	—	R 1 219	28d	—	—	—	—	—
A-CMF Variant #01	—	R 1 172	28d	—	—	—	—	—

26 of 26 regimens shown